| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Seed, Series A, Early Stage |
| Investing | Canada • France • Vietnam |
| Investment Range | €250,000 - €2,000,000 |
3CC, also known as Third Culture Capital, is a venture capital firm that focuses on investing in innovative startups at the intersection of culture and healthcare delivery. They aim to support diverse founders who demonstrate ingenuity and solid business practices to create significant disruptions in established markets. Their investment thesis centers on empowering global-minded leaders of industry who bring forth novel scientific advancements, technology, and innovative business models that aim to revolutionize the healthcare industry for the betterment of humanity.
Specifically, 3CC invests in companies that improve patient outcomes, reduce healthcare costs, and enhance the care experience for both patients and providers. They are interested in startups that converge technology and biology, looking at all modalities that have the potential to improve care delivery in an era of increasing tech-biological convergence.
The firm invests early, with funding ranging from $250,000 to $2,000,000, notably in seed and Series A rounds.
They often prefer to lead investment rounds and build strong syndicates to support the entrepreneurs they back. In addition to financial capital, 3CC provides human and cultural capital, using their healthcare network to help startups scale effectively.
They value the 'Third Culture' perspective, often associated with individuals who have spent their formative years in cultures different from their parents or their nationality, who as adults possess a unique, adaptable worldview, and are tolerant and intellectually flexible. This perspective is seen as valuable for finding common ground and innovative solutions in a globalized world.
Their heuristic-based approach to investing helps them identify and partner with the most ambitious founders to build businesses that can positively reshape the world for as many people as possible.
We invest in diverse founders who innovate at the intersection of culture and healthcare delivery.









